IS THERE ANY SIGNIFICANT IMPACT OF TWO DIFFERENT BIO-COMPATIBLE COATED CARDIOPULMONARY BYPASS CIRCUITS ON CIRCULATING PLATELET DROP

M SALEEM; LN KHAN; A MUSHTAQ

doi:10.54112/bcsrj.v2023i1.533

Authors

M SALEEM Department of Cardiac Surgery (Assist. Professor), Punjab Institute of Cardiology Lahore, Pakistan
LN KHAN Department of Cardiac Surgery (CPT), Punjab Institute of Cardiology Lahore, Pakistan
A MUSHTAQ Department of Cardiac Surgery (Cardiac Perfusionist), Punjab Institute of Cardiology Lahore, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2023i1.533

Keywords:

Cardiopulmonary bypass, phosphorylcholine coating, Balanced coating, Platelet drop

Abstract

Bleeding is common in cardiopulmonary bypass (CPB) surgery due to malfunctioning platelets. This study investigated the effect of a phosphorylcholine (PC)-coated CPB circuit and a balanced CPB circuit on platelet function. We conducted a descriptive, randomized trial at the Punjab Institute of Cardiology with 50 patients undergoing coronary artery bypass graft

(CABG) surgery (n=34), valve surgery (n=10), and CABG plus valvular replacement (n=6) using CPB. The patients were divided

into groups 1, which had phosphoryl-coated CPB, and 2, which had balanced-coated CPB. We measured and recorded pre- operative and post-operative levels of platelet count, white blood cells, and hemoglobin for both groups. We used the Student's t- test to make comparisons among groups, and the P values for both groups were less than 0.05 at a 95% confidence interval, indicating a significant impact of biocompatible coated CPB circuits on circulating platelet drop. Cohen's d formula showed that group 1 (Phosphoryl choline coating) had a more substantial effect on platelet drop than group 2 (Balanced coating). Blood component conservation, particularly platelet conservation, depends on the non-endothelium biocompatible surface used; the better the character, the more blood cells may be conserved. We looked at two coatings, phosphoryl coating, and balanced coating, to see if they substantially influenced platelet drop. According to the findings of our investigation, phosphoryl-coated CPB had a more significant influence on platelet drop than balanced coating.

Downloads

Download data is not yet available.

References

Anastasiadis, K., Antonitsis, P., Argiriadou, H., Anastasiadis, K., Antonitsis, P., and Argiriadou, H. (2013). Pathophysiology of Cardiopulmonary Bypass. Principles of Miniaturized ExtraCorporeal Circulation: From Science and Technology to Clinical Practice, 9-21.

Chandler, W. L., and Velan, T. (2003). Estimating the rate of thrombin and fibrin generation in vivo during cardiopulmonary bypass. Blood 101, 4355-4362.

De Somer, F., Van Belleghem, Y., Caes, F., Francois, K., Arnout, J., Bossuyt, X., Taeymans, Y., and Van Nooten, G. (2002a). Phosphorylcholine coating offers natural platelet preservation during cardiopulmonary bypass. Perfusion 17, 39-44.

De Somer, F., Van Belleghem, Y., Caes, F., Francois, K., Van Overbeke, H., Arnout, J., Taeymans, Y., and Van Nooten, G. (2002b). Tissue factor as the main activator of the coagulation system during cardiopulmonary bypass. The Journal of Thoracic and Cardiovascular Surgery 123, 951-958.

Downey, L. A., and Faraoni, D. (2023). Coagulation, Cardiopulmonary Bypass, and Bleeding. Anesthesia for Congenital Heart Disease, 377-408.

Knudsen, L., Hasenkam, J. M., Kure, H. H., Hughes, P., Bellaiche, L., Ahlburg, P., and Djurhuus, C. (1996). Monitoring thrombin generation with prothrombin fragment 1.2 assay during cardiopulmonary bypass surgery. Thrombosis research 84, 45-54.

Nouette, K., Richebé, P., Calderon, J., Mouton, C., Elalamy, I., and Janvier, G. (2004). Fonctions plaquettaires et risque hémorragique au cours de la circulation extracorporelle (CEC). Sang Thrombose Vaisseaux 16, 527-546.

Palanzo, D. A., Zarro, D. L., Manley, N. J., Montesano, R. M., Quinn, M., and Gustafson, P. A. (1999). Effect of surface coating on platelet count drop during cardiopulmonary bypass. Perfusion 14, 195-200.

Rana, S. (2021). The influence of cardiopulmonary bypass on acute renal failure after cardiac surgery.

Ray, M. J., Hawson, G. A., Just, S. J., McLachlan, G., and O'Brien, M. (1994). Relationship of platelet aggregation to bleeding after cardiopulmonary bypass. The Annals of thoracic surgery 57, 981-986.

Sniecinski, R. M., and Chandler, W. L. (2011). Activation of the hemostatic system during cardiopulmonary bypass. Anesthesia & Analgesia 113, 1319-1333.

Tesler, U. F. (2020). "A history of cardiac surgery: an adventurous voyage from antiquity to the artificial heart," Cambridge Scholars Publishing.

Vervoort, D., Meuris, B., Meyns, B., and Verbrugghe, P. (2020). Global cardiac surgery: access to cardiac surgical care around the world. The Journal of thoracic and cardiovascular surgery 159, 987-996. e6.

Wang, S., Griffith, B. P., and Wu, Z. J. (2021). Device-induced hemostatic disorders in mechanically assisted circulation. Clinical and Applied Thrombosis/Hemostasis 27, 1076029620982374.